“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease

“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) occurs when fat accumulates in the liver even without excessive alcohol intake. Among the current therapeutic approaches for NAFLD, lifestyle modification with dietary changes and regular exercise is the mainstay treatment. With the rise of intestinal microe...

Full description

Bibliographic Details
Main Authors:	Kangxiao Guo, Sisheng Xu, Zhaofeng Zeng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Endocrinology
Subjects:	“liver–gut” axis intestinal microorganisms traditional Chinese medicine NAFLD target
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1050709/full

Similar Items

Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis
by: Xiang Chen, et al.
Published: (2022-10-01)

Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis
by: Weifeng Zhu, et al.
Published: (2022-05-01)

The gut-liver axis in fatty liver disease: role played by natural products
by: Zhu Ming, et al.
Published: (2024-04-01)

Traditional Chinese medicine for the treatment of Alzheimer's disease: A focus on the microbiota–gut–brain axis
by: Lina Ma, et al.
Published: (2023-09-01)

Tiny but mighty: Possible roles of bacterial extracellular vesicles in gut‐liver crosstalk for non‐alcoholic fatty liver disease
by: Li Shao, et al.
Published: (2022-09-01)

Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science
by: Shuwei Zhang, et al.
Published: (2020-09-01)

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
by: Yiming Ni, et al.
Published: (2022-06-01)

Low Short-Chain-Fatty-Acid-Producing Activity of the Gut Microbiota Is Associated with Hypercholesterolemia and Liver Fibrosis in Patients with Metabolic-Associated (Non-Alcoholic) Fatty Liver Disease
by: Xinlu Cao, et al.
Published: (2023-10-01)

Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
by: Li J, et al.
Published: (2023-06-01)

Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
by: Xiao-Fang Yang, et al.
Published: (2021-07-01)

The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
by: Jiayi Liu, et al.
Published: (2022-08-01)

Dietary Intervention Reverses Fatty Liver and Altered Gut Microbiota during Early-Life Undernutrition
by: K. C. Bauer, et al.
Published: (2020-10-01)

Lentinan Supplementation Protects the Gut–Liver Axis and Prevents Steatohepatitis: The Role of Gut Microbiota Involved
by: Xiaoying Yang, et al.
Published: (2022-01-01)

Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
by: Alejandra Mijangos-Trejo, et al.
Published: (2023-10-01)

Gut microbiota: A new target of traditional Chinese medicine for insomnia
by: Wanying Feng, et al.
Published: (2023-04-01)

Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
by: Anna Gudan, et al.
Published: (2023-03-01)

Progress on traditional Chinese medicine in treatment of ischemic stroke via the gut-brain axis
by: Zhe Zhai, et al.
Published: (2023-01-01)

Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
by: Xing Ying, et al.
Published: (2023-01-01)

Viral Liver Disease and Intestinal Gut–Liver Axis
by: Elias Kouroumalis, et al.
Published: (2024-01-01)

Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis
by: Shuangjie Yang, et al.
Published: (2023-03-01)

Editorial: Gut-lung interaction axis
by: Jiang Pi, et al.
Published: (2023-02-01)

Polysaccharide from <i>Salviae miltiorrhizae</i> Radix et Rhizoma Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease through Modulating Intestinal Microbiota-Related Gut–Liver Axis
by: Lixia Li, et al.
Published: (2022-09-01)

Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
by: Salvatore Pezzino, et al.
Published: (2022-11-01)

The gut-liver axis in hepatobiliary diseases
by: Masataka Ichikawa, et al.
Published: (2024-01-01)

Research Progress on Gut-Liver Axis Mediated Nonalcoholic Fatty Liver Disease and Its Nutritional Intervention
by: XU Ye, HU Yanzhou, XU Jia, HUANG Xianghui, HUANG Kunlun, HE Xiaoyun
Published: (2023-02-01)

The microbiota–gut–brain axis and its modulation in the therapy of depression: Comparison of efficacy of conventional drugs and traditional Chinese medicine approaches
by: Chenchen Bi, et al.
Published: (2022-09-01)

Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
by: Anna eAlisi, et al.
Published: (2012-10-01)

Traditional Chinese Medicine formula Dai-Zong-Fang alleviating hepatic steatosis in db/db mice via gut microbiota modulation
by: Li-Wei Zhang, et al.
Published: (2024-01-01)

The Gut–Liver Axis in Pediatric Liver Health and Disease
by: Stephanie L. Rager, et al.
Published: (2023-02-01)

The Molecular and Mechanistic Insights Based on Gut–Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement
by: Yun Ji, et al.
Published: (2020-04-01)

Gut brain interaction theory reveals gut microbiota mediated neurogenesis and traditional Chinese medicine research strategies
by: Chenxi Zhang, et al.
Published: (2022-12-01)

Probiotics as Potential Therapeutic Agents: Safeguarding Skeletal Muscle against Alcohol-Induced Damage through the Gut–Liver–Muscle Axis
by: Martina Sausa, et al.
Published: (2024-02-01)

Dendrobii Officinalis, a traditional Chinese edible and officinal plant, accelerates liver recovery by regulating the gut-liver axis in NAFLD mice
by: Shan-Shan Lei, et al.
Published: (2019-10-01)

Microbiota Dysbiosis and Gut Barrier Dysfunction Associated with Non-Alcoholic Fatty Liver Disease Are Modulated by a Specific Metabolic Cofactors’ Combination
by: Sergio Quesada-Vázquez, et al.
Published: (2022-11-01)

Correlation of non-alcoholic fatty liver disease and gut microflora: clinical reports and treatment options
by: Pranali A. Jadhav, et al.
Published: (2024-04-01)

Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis
by: Tian Lan, et al.
Published: (2022-06-01)

Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
by: Qi Zhang, et al.
Published: (2022-09-01)

Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
by: Sergio Quesada-Vázquez, et al.
Published: (2020-01-01)

Advances in the study on brain-gut axis mechanism of common mental disorders and clinical intervention
by: Hu Shaohua
Published: (2023-06-01)

The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease
by: Zhonglin Li, et al.
Published: (2023-08-01)